BCPS Board Certified Pharmacotherapy Specialist Practice Test
The Board Certified Pharmacotherapy Specialist (BCPS) certification, administered by the Board of Pharmacy Specialties (BPS), is the premier credential for pharmacists demonstrating advanced knowledge and expertise in pharmacotherapy. This rigorous certification validates a pharmacist's ability to manage complex medication therapy across diverse patient populations and disease states. BCPS-certified professionals are recognized for their comprehensive understanding of drug therapy selection, monitoring, and optimization, serving as integral members of interdisciplinary healthcare teams. Achieving BCPS certification signifies a commitment to the highest standards of patient care, evidence-based practice, and continuous professional development. It is the foundational specialty certification upon which many other BPS specialties build, making it highly versatile and respected across all practice settings, including hospitals, ambulatory care, academia, and industry. The credential is a testament to a pharmacist's dedication to advancing the profession and improving patient outcomes through expert medication management.
नमूना प्रश्न
पूरी परीक्षा कैसी है देखने के लिए कुछ प्रश्न आज़माएं।
A 41-year-old man with generalized convulsive status epilepticus receives lorazepam twice and is still seizing 8 minutes later. Glucose is normal, sodium is 137 mEq/L, and he has no known epilepsy history. Which next medication strategy is most appropriate?
A 25-year-old man taking clozapine for schizophrenia has ANC 1,100/mm3 after previously normal counts. He is afebrile and psychiatrically stable. The clinic asks why repeat labs are needed next week. What is the best explanation?
A 60-year-old woman with type 2 diabetes, BMI 36 kg/m2, prior MI, and eGFR 70 mL/min/1.73 m2 takes metformin. HbA1c is 8.4%. She wants weight loss and has no history of pancreatitis or medullary thyroid carcinoma. Which add-on best fits current outcome-focused therapy?
A 46-year-old woman receives once-daily gentamicin for pyelonephritis. Her creatinine rises from 0.8 to 1.3 mg/dL on day 3, and the random concentration plots above the nomogram line. She feels better and is afebrile. What is the best monitoring-based action?
A 69-year-old man with COPD has CAT score 18 and two prednisone-treated exacerbations in the past year despite umeclidinium-vilanterol. Blood eosinophils are 360 cells/mm3. He has no pneumonia history and no asthma diagnosis. Which maintenance change is most appropriate?